Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide.
about
Reduced ABCB1 Expression and Activity in the Presence of Acrylic Copolymers.Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticles.
P2860
Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Development, in vitro and in v ...... availability of acetazolamide.
@en
Development, in vitro and in v ...... availability of acetazolamide.
@nl
type
label
Development, in vitro and in v ...... availability of acetazolamide.
@en
Development, in vitro and in v ...... availability of acetazolamide.
@nl
prefLabel
Development, in vitro and in v ...... availability of acetazolamide.
@en
Development, in vitro and in v ...... availability of acetazolamide.
@nl
P2093
P2860
P1433
P1476
Development, in vitro and in v ...... availability of acetazolamide.
@en
P2093
Arvind Kumar Jha
Parmanand Verma
Roop Narayan Gupta
P2860
P304
P356
10.3109/10717544.2013.834417
P407
P577
2013-09-01T00:00:00Z